Investors
Key press releases
Key upcoming events
Key corporate presentation
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$19.4100
-0.1000 (-0.5126%)
- Prev. close
- 19.5100
- Volume
- 42,918
- High
- 19.8200
- Capitalization
- 830.363M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€16.3300
-0.3400 (-2.0396%)
- Prev. close
- 16.6700
- Volume
- 52,182
- High
- 16.5500
- Capitalization
- 693.848M
Covering research analysts
Barclays - Gena Wang
Citi - Yigal Nochomovitz
Goldman Sachs - Salveen Richter
Guggenheim - Michael Schmidt
Jefferies – Biren Amin
Jones Trading - Soumit Roy
Kempen - Ingrid Gafanhão
Ladenburg – Wangzhi Li
Oddo BHF - Martial Descoutures
Oppenheimer – Hartaj Singh
Portzamparc – Christophe Dombu
RW Baird - Madhu Kumar
Wells Fargo – Jim Birchenough
William Blair – Raju Prasad
Cellectis contact information
Simon Harnest
Investor Relations USA
+1 646 385 9008
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89